GoodRx Holdings Inc (NASDAQ: GDRX) is -7.01% lower on its value in year-to-date trading and has touched a low of $4.14 and a high of $9.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GDRX stock was last observed hovering at around $6.54 in the last trading session, with the day’s loss setting it -0.31%.
Currently trading at $6.23, the stock is -9.17% and -14.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.77 million and changing -4.74% at the moment leaves the stock -14.80% off its SMA200. GDRX registered 13.27% gain for a year compared to 6-month loss of -12.01%. The firm has a 50-day simple moving average (SMA 50) of $7.286 and a 200-day simple moving average (SMA200) of $7.31195.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -6.88% gain in the last 1 month and extending the period to 3 months gives it a -29.60%, and is -9.45% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.60% over the week and 3.33% over the month.
GoodRx Holdings Inc (GDRX) has around 694 employees, a market worth around $2.36B and $775.09M in sales. Fwd P/E is 14.21. Profit margin for the company is -7.57%. Distance from 52-week low is 50.67% and -32.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-4.30%).
GoodRx Holdings Inc quarterly earnings per share for the current quarter are estimated at 0.09 with sales reaching $195.65M over the same period.The EPS is expected to grow by 23.79% this year, but quarterly earnings will post 6.70% year-over-year. Quarterly sales are estimated to grow 8.70% in year-over-year returns.
226.0 institutions hold shares in GoodRx Holdings Inc (GDRX), with institutional investors hold 74.12% of the company’s shares. The shares outstanding are 92.36M, and float is at 81.18M with Short Float at 11.13%. Institutions hold 64.91% of the Float.
The top institutional shareholder in the company is FRANCISCO PARTNERS MANAGEMENT, LP with over 70.08 million shares valued at $546.61 million. The investor’s holdings represent 17.9666 of the GDRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.13 million shares valued at $63.43 million to account for 2.0849 of the shares outstanding. The other top investors are AMERIPRISE FINANCIAL INC which holds 5.18 million shares representing 1.3287 and valued at over $40.42 million, while MILLENNIUM MANAGEMENT LLC holds 1.0568 of the shares totaling 4.12 million with a market value of $32.15 million.
GoodRx Holdings Inc (GDRX) Insider Activity
The most recent transaction is an insider sale by Spectrum Equity VII, L.P., the company’s 10% Owner. SEC filings show that Spectrum Equity VII, L.P. sold 10,677 shares of the company’s common stock on Sep 03 ’24 at a price of $7.86 per share for a total of $83922.0. Following the sale, the insider now owns 0.0 shares.
Still, SEC filings show that on Sep 03 ’24, Spectrum VII Co-Investment Fun (Affiliate) Proposed Sale 3,849 shares at an average price of $7.86 for $30253.0. The insider now directly holds shares of GoodRx Holdings Inc (GDRX).
